SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUE	$ 3,028,945	$ 3,449,159
COST OF REVENUE	(2,695,406)	(2,866,594)
GROSS PROFIT	333,539	582,565
OTHER INCOME	46,394	62,388
PROFIT BEFORE TAX	31,365	338,744
Tax expense	14,299	0
Net profit	17,066	338,744
TOTAL [Member]
REVENUE	3,028,945	3,449,159
COST OF REVENUE	(2,695,406)	(2,866,594)
GROSS PROFIT	333,539	582,565
OTHER INCOME	46,394	62,388
General and administrative	(345,242)	(302,851)
FINANCE COSTS	(3,326)	(3,358)
PROFIT BEFORE TAX	31,365	338,744
Tax expense	(14,299)	0
Net profit	17,066	338,744
BioNexus Malaysia [Member]
REVENUE	24,269	97,363
COST OF REVENUE	(30,832)	(67,707)
GROSS PROFIT	(6,563)	29,656
OTHER INCOME	2,076	763
General and administrative	(21,248)	(22,511)
FINANCE COSTS	(799)	(1,207)
PROFIT BEFORE TAX	(26,534)	6,701
Tax expense	0	0
Net profit	(26,534)	6,701
Chemrex [Member]
REVENUE	3,004,676	3,351,796
COST OF REVENUE	(2,664,574)	(2,798,887)
GROSS PROFIT	340,102	552,909
OTHER INCOME	44,306	61,625
General and administrative	(297,769)	(233,152)
FINANCE COSTS	(2,527)	(2,151)
PROFIT BEFORE TAX	84,112	379,231
Tax expense	(14,299)	0
Net profit	69,813	379,231
BGLC [Member]
REVENUE	0	0
COST OF REVENUE	0	0
GROSS PROFIT	0	0
OTHER INCOME	12	0
General and administrative	(26,225)	(47,188)
FINANCE COSTS	0	0
PROFIT BEFORE TAX	(26,213)	(47,188)
Tax expense	0	0
Net profit	$ (26,213)	$ (47,188)